AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT
Recruiting
Observational Study
Gastric Cancer Stage
Gastric Cancer Patients Undergoing Gastrectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 8,000 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Accurate preoperative assessment of gastric cancer stage guides eligibility for endoscopic resection, extent of gastrectomy and lymphadenectomy, selection for neoadjuvant therapy, and use of staging laparoscopy. Contrast-enhanced CT (CECT) is guideline-endorsed for initial staging, yet performance varies across institutions and readers. This study will evaluate an artificial-intelligence (AI) syst…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. pathologically confirmed gastric cancer;
2. preoperative contrast-enhanced CT performed;
3. no evidence of distant metastasis on baseline staging;
4. curative-intent management with complete postoperative histopathology.
Exclusion Criteria:
1. prior treatment before surgery…
Contacts